Hamilelikte ibuprofen kullanmaktan kaçınmalı mıyım? | VeriMom
Ibuprofen (CAS 15687-27-1) is an NSAID with human/animal evidence of adverse fetal effects (fetal renal dysfunction/oligohydramnios and premature ductus arteriosus closure) prompting an FDA warning to avoid NSAID use at ≈20 weeks gestation and later; this supports a 'suspected' reproductive hazard (h=2). The mechanism is demonstrated (prostaglandin inhibition → fetal renal/ductus arteriosus effects), so m=2. Topical/cosmetic use yields low but measurable systemic exposure vs oral use, so exposure for topical cosmetic use is low (e=1). Sources: FDA, MotherToBaby/NCBI, ECHA substance information.
ECHA regulatory hazard statements
- •H360
- •H361
- •H362
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ibuprofen hamilelikte güvenli mi?
- Ibuprofen (CAS 15687-27-1) is an NSAID with human/animal evidence of adverse fetal effects (fetal renal dysfunction/oligohydramnios and premature ductus arteriosus closure) prompting an FDA warning to avoid NSAID use at ≈20 weeks gestation and later; this supports a 'suspected' reproductive hazard (h=2). The mechanism is demonstrated (prostaglandin inhibition → fetal renal/ductus arteriosus effects), so m=2. Topical/cosmetic use yields low but measurable systemic exposure vs oral use, so exposure for topical cosmetic use is low (e=1). Sources: FDA, MotherToBaby/NCBI, ECHA substance information.
- ibuprofen emzirirken güvenli mi?
- Available clinical guidance and reviews indicate very low transfer of ibuprofen into human milk and no documented infant harm for usual maternal doses; therefore no reproductive/breastfeeding hazard is indicated (h=0, m=0). Milk transfer is measurable but low, so e=1. Sources: MotherToBaby (NCBI), NHS Specialist Pharmacy Service; clinical references note ibuprofen is generally compatible with breastfeeding.
- ibuprofen bebek cildi için güvenli mi?
- Hazard (h=2) is carried over because systemic reproductive/toxicity evidence for ibuprofen exists (see pregnancy summary). Per instructions, infant-specific hazard or mechanism were not found so h and m are not increased beyond adult evidence (m=2). Topical exposure for infants is increased relative to adults (immature barrier and higher surface-area-to-weight) so exposure is raised by +1 (adult e=1 → baby e=2). No infant-specific studies were found showing different hazard; precautionary higher exposure score applied.
- VeriMom ibuprofen nasıl puanlıyor?
- VeriMom ibuprofen'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.
- Hamilelikte ibuprofen yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.